ST. LOUIS, MO--(Marketwired - May 07, 2014) - Murphy Analytics (MA) has updated coverage on Axxess Pharma Inc. (PINKSHEETS: AXXE). The Update Report contains a detailed discussion of AXXE's planned business operations, market dynamics, financials, potential cash flows, and risks. The Update Report is available at: http://www.murphyanalytics.com/uploads/AXXE_Update.pdf.
Analyst Patrick Murphy notes in the report: "A review of AXXE press releases over the preceding quarters sheds light on the Company's optimism as AXXE has made a significant number of improvements and expansions of its distribution channels, product lineup, marketing efforts, and corporate operations. The Company's 5/1/14 announcement that TapouT will be available in over 160 U.S. military stores reflects both the substantial progress AXXE has made as well as the opportunity before the company."
About Murphy Analytics
Murphy Analytics is an independent investment research firm providing coverage of microcap stocks. Utilizing institutional caliber, fundamental analysis, Murphy Analytics helps readers become more informed about equities without extensive analyst coverage. Murphy Analytics LLC is owned by Patrick J. Murphy, who has nearly 20 years of capital markets experience, providing institutional investment and transaction analysis across a range of asset classes including microcap equities, commercial real estate debt and equity, municipal derivatives and public finance, venture capital, fixed income, CMBS and mortgage REIT's.
Disclosure: MA was paid $5,000 by the Company in advance of the publication of an Initiation Report dated 11/5/13 and $2,500 in advance of the publication of this report. Neither MA nor the analyst owns or trades the shares of covered companies. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. MA provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, experience, or results. This report is neither a solicitation to buy nor an offer to sell securities and is to be used for informational purposes only and should not be used as basis for investment decisions. MA is not an investment advisor or broker/dealer and this report does not provide investment advice.